Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

 

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
S

Case of 54/m With Thrombotic Microangiopathy: Differentiating TTP and aHUS, Ravulizumab for aHUS / Case of 27/F With aHUS: Approach to Eculizumab Discontinuation and Monitoring

By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Shruti Chaturvedi
By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Shruti Chaturvedi
168 views
March 16, 2020
0 Comments
Login to view comments. Click here to Login
Nonmalignant Hematology
06:25
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: Full-Dose or Intermediate-Dose DOAC?

Feat. S. Moll
13:54
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: What is the Optimal Duration of Anticoagulation with DOACs l…

Feat. S. Moll
11:29
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: How Can We Improve on Existing Oral Anti…

Feat. J. Eikelboom
10:02
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: What are the Unmet Needs?

Feat. J. Eikelboom
25:59
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Approach to Thrombocytopenia in the Hospitalized Patient

Feat. J. Kelton
17:54
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Key Concept of Heparin-induced Thrombocytopenia in 2020: Approach &a…

Feat. J. Kelton
21:26
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Case of 54/m With Thrombotic Microangiopathy: Differentiating TTP an…

Feat. S. Chaturvedi
14:03
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Role of Complement Activation in HELLP and CAPS & Complement in …

Feat. S. Chaturvedi
20:32
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Algorithms to Minimize Bleeding in At Risk Patient Populations on An…

Feat. J. Green
10:10
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Considerations on Oral Anticoagulant Use After Bariatric Surgery &am…

Feat. J. Green
24:44
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Diagnosis of Waldenstrom Macroglobulinemia: MYD88 Mutation Status, I…

Feat. M. Gertz
18:52
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of Waldenstrom Macroglobulinemia: Bendamustine Based Thera…

Feat. M. Gertz
36:18
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Understand Principles of Diagnosing Von Willebrand Disease and Its S…

Feat. A. Ma
07:08
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Difficulties in Testing for Von Willebrand Disease & Treatment O…

Feat. A. Ma
05:55
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

VTE in Cancer: Risk Factors, DOACS are Reasonable Choice, Less Recur…

Feat. S. Moll
20:20
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: Duration of Anticoagulation, Full-Dose or Intermediate-Dose …

Feat. S. Moll
13:35
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DOAC Update: Use in Obese Pts, DOAC vs VKA, APS and DOACs

Feat. S. Moll
05:33
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

54 y/o Man on Long-term Rivaroxaban Needs Screening Colonoscopy: Whe…

Feat. S. Moll
17:39
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Challenges of Anticoagulant Selection, Dosing, and Administration in…

Feat. M. Pai
14:36
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Monitoring, Interrupting, Reversing Anticoagulants, Management of DO…

Feat. M. Pai
23:45
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: Unmet Needs & Improving on Existing …

Feat. J. Eikelboom
11:34
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Are There Ways Other Than Directly Targeting Coagulation to Reduce t…

Feat. J. Eikelboom